Press release
United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month
- Neuroblastoma is the most common cancer in infants less than one year old and the third-most common pediatric cancer in children less than 15 years old,
About this update from United Therapeutics Corporation
[{"type":"text","content":"- Neuroblastoma is the most common cancer in infants less than one year old and the third-most common pediatric cancer in children less than 15 years old, accounting for 15 percent of childhood cancer deaths [i],[ii],[iii]\n - Diagnosed at age four with high-risk neuroblastoma, cancer survivor Leah and her father Devon join United Therapeutics to recognize and support families impacted by this difficult-to-treat cancer at all stages of the patient journey - from recent diagnosis to during and after treatment\n - For more than two decades, United Therapeutics Oncology has been a pioneering partner in the fight against high-risk neuroblastoma\n\n\nSILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced it is joining forces with former NFL player Devon Still and his daughter Leah, a survivor of high-risk neuroblastoma, to launch the educational initiative \"Braving NeuroBLASToma\" shining a light on the rare cancer affecting immature nerve cells called neuroblasts.iv Neuroblastoma often develops in infants and children under the age of five, but the average age of diagnosis is between one and two years old.\n\n \n \n \n \n \n \n\n \nEach year, about 800 children are diagnosed with neuroblastoma, accounting for seven to ten percent of all childhood cancers in the United States. v, vi At the time of diagnosis, nearly 70 percent of children will have advanced or metastatic neuroblastoma, with only half of these patients achieving remission.vii,viii Neuroblastoma can start to form in several places including near the abdomen, spine, chest, or adrenal glands.ix \n\n \"When I first learned that Leah had high-risk neuroblastoma, the sense of fear and helplessness was so overwhelming that I struggled to know where to begin,\" said Devon Still. \"Over the years, so many in the childhood cancer community have shown us how much they care each and every step of the way, from making the tough decisions to ensuring Leah's comfort while undergoing treatment. Partnering with United Therapeutics enables us to share our personal experiences with braving neuroblastoma and lend others the support we so generously received throughout the years.\"\n\n Braving NeuroBLASToma features:\n\n \n A family-friendly toolkit with a resource-rich website, including a comprehe...